SyntheticMR

SyntheticMR occupies a specialist position in MRI software, focused on deriving quantitative tissue information and multiple adjustable contrast-weighted images from MRI data. SyMRI Neuro targets neurological assessment with tissue segmentation and volume measurements, while SyMRI MSK applies quantitative imaging to musculoskeletal use cases; cNeuro combines neuroimaging analysis with clinical data and AI-supported decision tools. This focus differentiates the company from conventional MRI workflows centered on standard image contrasts, by seeking to extract additional measurements from an examination and support faster acquisition and processing. The company’s stated partner ecosystem includes GE Healthcare, Siemens Healthineers and Philips Healthcare, and its 2026 cNeuro agreements with 3DR Labs and Terarecon add distribution and workflow integration in the United States. These relationships indicate a strategy of working alongside imaging equipment and service providers rather than replacing MRI scanners. SyntheticMR’s scale—an employee band of 11–50—and its focused software portfolio contrast with the broader product scope of major imaging equipment companies. Its competitive position therefore depends on clinical adoption, integration into hospital workflows and demonstrating the value of quantitative outputs across neurological and musculoskeletal imaging.

SyntheticMR’s trajectory combines product expansion, geographic commercialization and organizational adjustment. The company was founded in 2007 and has developed a portfolio spanning SyMRI Neuro, SyMRI MSK and cNeuro. A notable product milestone was SyMRI in 3D in November 2024, followed by FDA 510(k) clearance for SyMRI 15 in December 2024. SyntheticMR acquired Combinostics on November 28, 2024, for €4.3 million (approximately $4.54 million), adding an interdisciplinary neuroimaging platform to its offerings. Commercial activity broadened in 2026: cNeuro cMRI with automated ARIA detection entered the Indian market in January, and May partnerships with 3DR Labs and Terarecon supported US distribution and workflow integration. The organization also optimized following the Combinostics acquisition, reducing employee numbers primarily in Sweden.